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ABSTRACT: When ovariectomized female rats receive estrogen, the re-
sponse to the psychomotor stimulants amphetamine or cocaine is en-
hanced. Estrous cycle-dependent differences in amphetamine-stimulated
behaviors and striatal dopamine release are also noted. Intact female rats
exhibit a greater behavioral response to amphetamine on estrus than they
do on other days of the cycle. Ovariectomy results in attenuation of am-
phetamine-induced behavior and the striatal dopamine response to am-
phetamine. Physiological doses of estrogen given to ovariectomized rats
reinstate both of these responses to a level comparable to that in estrous fe-
males. Furthermore, a sex difference is noted, in that females tend to ex-
hibit a greater behavioral response to the psychomotor stimulants, and
estrogen enhances this sex difference. Repeated treatment with amphet-
amine or cocaine produces a progressive increase in behavioral responsive-
ness with subsequent drug administration, a process known as
sensitization. In rodents, behavioral sensitization results in increases in
both frequency and duration of psychomotor behaviors such as rotational
behavior, stereotyped grooming, headbobs, and forelimb movements. In-
terestingly, females display greater sensitization of behaviors in response
to psychomotor stimulants than do males. Previous research results are
summarized, and new results are presented, demonstrating that estrogen
selectively enhances components of behavior that exhibit sensitization in
female rats. Results also indicate gender differences in sensitization inde-
pendent of gonadal hormones, suggesting that the neural systems that un-
dergo sensitization are sexually dimorphic.
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INTRODUCTION
The use of all illicit drugs has been increasing among women in the last
decade. In particular, cocaine dependence among women is a growing public
health concern.1 While males have historically been seen as the primary users
of illicit drugs, 9% of women over the age of 12 have used cocaine. Marijuana
is the only illicit drug used more frequently by women (28% have used mar-
ijuana).2 Of particular concern is the finding that women are more likely to
become addicted to cocaine, if they have used it, than to any other drug.
Among the women who have used cocaine, the prevalence of lifetime depen-
dence is 14.9 ± 2.0% (mean ± SD). By contrast, 79% of women have used
alcohol, but only 9.2 ± 0.8% have developed lifetime dependence.2 With gen-
der differences in the use of illicit drugs diminishing, it is necessary to con-
sider whether gender differences exist in the neural mechanisms mediating
the effects of cocaine and the likelihood of becoming addicted to this drug.
We know that there are gender differences in some of the acute subjective
responses to psychomotor stimulant drugs.3 In a recent study of the acute
subjective effects of amphetamine (AMPH) in women, higher levels of estro-
gen were associated with greater AMPH-induced increases in “euphoria” and
“energy and intellectual efficiency.”3 Gender differences and significant ef-
fects of the menstrual cycle on peak plasma cocaine were also noted after in-
tranasal administration.4 Furthermore, the pattern of cocaine use and the
onset of addiction to cocaine are more rapid in women than in men.5
As evident from a review of the animal literature which follows, results in
humans parallel, to some extent, those in rodents. Here, female rats exhibit a
greater initial behavioral response to AMPH or cocaine and show an even
greater rate of enhanced behavioral response to subsequent treatments (i.e.,
sensitization) than do males. Basic research on the role of gender and ovarian
hormones in the response to acute and repeated exposure to cocaine and
AMPH may enhance our understanding of the processes involved in gender
differences in drug abuse. The Becker laboratory has been investigating how
estrogen acts in the striatum of the rat to affect the neurotransmitter dopamine
(DA) and the behavioral responses to psychomotor stimulant drugs.
The ascending DA projection from the midbrain to the dorsal and ventral
striatum is a massive projection, within which over 90% of the DA in the
brain resides.6 Administration of drugs that activate or inhibit DA systems in-
duces behaviors that are due primarily to activity in this ascending DA sys-
tem. Investigated behaviors, that is, rotational behavior or stereotyped
behaviors, have been shown to be mediated primarily by the nigrostriatal DA
system.7–11 Thus, these behaviors can be used as an index, or behavioral as-
say, of DA activity in the striatum.
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For example, a low dose of AMPH induces rotational behavior in rats due
to endogenous asymmetry in the nigrostriatal DA system.12 When males are
given a dose of 1.56 mg/kg AMPH and females receive 1.25 mg/kg AMPH
(to overcome gender differences in AMPH metabolism), striatal concentra-
tions of AMPH are equivalent during the behavioral testing period, but male
rats turn significantly less than do female rats at all stages of the estrous cycle
except for metaestrus.13 In this experiment, animals were tested during the
dark phase of the light:dark cycle, and ovarian hormones were at their lowest
during metaestrus. A role for ovarian hormones in modulating rotational be-
havior is demonstrated by the finding that gonadectomy results in a signifi-
cant decrease in rotational behavior in female, but not male rats. In fact, after
ovariectomy (OVX) there is a decrease in rotational behavior induced by ei-
ther AMPH or unilateral electrical stimulation of the ascending DA projec-
tion to the striatum behavior.14,15 In the same experiments, there was no
effect of castration in male rats on rotational behavior.14,15 Thus, the effect of
OVX to attenuate the behavioral response to and the gender differences in-
duced during DA activation are not unique to the effect of AMPH, but are ap-
parently more general properties of the ascending DA system.
Selective hormone replacement experiments demonstrate that estrogen
alone is sufficient to enhance rotational behavior in the ovariectomized fe-
male rat.16 Importantly, while rotational behavior or stereotyped behavior is
enhanced by repeated estrogen treatment (hormone treatment to approximate
estrogen exposure during the estrous cycle), a single dose of 5 µg estradiol
benzoate (EB) 30 minutes prior to AMPH is sufficient to induce a significant
increase in AMPH-induced behaviors.17,18 Thus, acute estrogen treatment
rapidly induces an increase in behavioral measures of nigrostriatal DA activ-
ity. This is an important point, as it suggests that the mechanism mediating
the effect of estrogen in the striatum is different from that mediated by clas-
sical estrogen receptors, which usually take hours to days to produce changes
in behavior.
Furthermore, in vivo microdialysis to determine extracellular concentra-
tions of DA in striatum indicates estrous cycle-dependent variation in the
AMPH-induced increase of DA in striatum. Female rats during estrus have a
significantly greater AMPH-induced increase in extracellular DA in striatum
than do female rats during metaestrus.19 During microdialysis in the same an-
imals, females in estrus exhibited significantly more stereotyped behavior
than did animals in metaestrus.19 In addition, a single dose of 5 µg EB given
to ovariectomized rats enhances the AMPH-induced increase in extracellular
striatal DA coincident with enhanced rotational behavior.17 The effect of
acute estrogen treatment to enhance AMPH-induced DA in striatum and
AMPH-induced behaviors is found in ovariectomized female rats but not in
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castrated male rats.20 Thus, a sex difference exists in the effect of estrogen in
the striatum.
The results of the microdialysis experiments lead to the question of wheth-
er the effects of estrogen on DA-mediated behaviors cause the effects on stri-
atal DA release just described or whether the effects of estrogen on striatal
DA release induce the reported effects on behavior. Experiments to examine
DA release from striatal tissue in vitro can be used to demonstrate the causal
relation between these events. Using an in vitro superfusion system to study
DA release from striatal tissue, we have confirmed that: (1) AMPH-induced
striatal DA release varies with estrous cycle21; (2) OVX attenuates AMPH-
induced striatal DA release, whereas castration of male rats has no effect on
this measure21,22; and (3) estrogen treatment enhances AMPH-stimulated
striatal DA release in striatal tissue from female but not male rats.21,22 From
these experiments we conclude that the effects of estrogen on striatal DA re-
lease occur in the absence of behavior. Thus, the effects of estrogen on striatal
DA release likely mediate the changes in behavior that occur.
With an in vitro superfusion system estrogen can be delivered directly to
striatal tissue slices to determine whether it is acting directly on the striatum
to produce its effects on the striatum. Thus, it is an important finding that es-
trogen in physiological concentrations (100 pg/ml) acts directly on the stria-
tum of ovariectomized female rats to enhance AMPH- or K+-stimulated DA
release.21,23 Furthermore, the pulsatile administration of estrogen directly
stimulates DA release in striatal tissue from female rats, but not male rats.21
These results indicate that the acute effects of estrogen on striatal DA and on
DA-mediated behavior are most likely due to the direct effects of estrogen on
the striatum.
Experiments using whole-cell clamp electrophysiology in acutely dissoci-
ated striatal neurons support the idea of rapid, direct effects of estrogen in the
striatum. Estrogen inhibits L-type Ca2+ channels in striatal neurons.24 The ef-
fects occur within seconds, reverse as soon as estrogen delivery ceases, and
are seen at physiological concentrations of estrogen (i.e., pM). Furthermore,
cells from females show a greater response than do cells from the striatum of
males. Estrogen conjugated to a large protein to prevent the entry of estrogen
into the cell is also effective. In addition, estrogen applied internally to cells
through the electrode is not effective in reducing Ca2+ currents and does not
block the effect of 1 pM estrogen applied externally. Collectively, these re-
sults suggest that the effect of estrogen occurs externally at the membrane
surface. In the presence of GTPγS (which prevents inactivation of G-protein
mediated events), the effect of 17β-estradiol does not reverse when hormone
delivery ceases. Thus, the effect of estrogen on striatal neurons apparently de-
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pends on a G-protein–coupled receptor. Finally, the effect of 17β-estradiol is
stereospecific, as 17α-estradiol does not mimic the modulation, and steroid-
specific as 100 pM estrone and 3-methoxyestriol were ineffective while estri-
ol or 4-hydroxy-estradiol mimic the effect of 17β-estradiol. These results in-
dicate, therefore, that estrogen has rapid stereospecific effects on striatal
neurons that alter signaling pathways independent of the classical estrogen
receptor.24
BEHAVIORAL SENSITIZATION
Gender differences in and hormonal influences on the acute effects of the
psychomotor stimulants are just part of the complex way in which these drugs
act in the brain. The reason is that the effects of cocaine and AMPH change
with repeated administration. These changes take two general forms: toler-
ance or sensitization.25,26 Tolerance, and its role in the development of phys-
ical dependence, has been a focus of addiction research for many years.25,27–
30 More recently, the role of sensitization-related neuroadaptations in the pro-
cess of addiction has become an important area of research as well.26, 31–39
Behavioral sensitization refers to an increase in drug effect with repeated
drug administration. Although most drug effects do not undergo sensitiza-
tion, two major classes do: the psychomotor stimulant effects and the incen-
tive motivational or rewarding effects of these drugs. The psychomotor
stimulant effects that show sensitization include locomotor hyperactivity, ste-
reotyped behavior, and rotational behavior.40–42 The association between
sensitization and addiction is indicated by the influence of prior drug expo-
sure on the later acquisition of a conditioned place preference35,43–45 or drug
self-administration behavior.33,34,36,46–50 The results of these and other stud-
ies suggest a relationship between drug-seeking behavior and drug
sensitization.
One of the most remarkable features of sensitization is its persistence. Sen-
sitization to AMPH, cocaine, or morphine has been reported to last weeks to
months following the discontinuation of pretreatment.51 Furthermore, sensi-
tization to treatment with escalating doses of AMPH persists at least a year
in the rat.52 With some treatment regimens, however, the persistence of co-
caine sensitization may be much more transient.53–55 Sensitization has been
the topic of a number of review articles to which the reader is referred for ad-
ditional information (e.g., Refs. 40, 41, and 56–61). It is beyond the scope of
this article to provide a complete treatment of the topic.
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GENDER DIFFERENCES IN SENSITIZATION TO
PSYCHOMOTOR STIMULANTS
Female rats generally exhibit more robust sensitization in response to
AMPH (i.e., a greater absolute increase in psychomotor behavior) than do in-
tact males.42,62–66 Although the effects of AMPH sensitization studies are
confounded by gender differences in AMPH metabolism, gender differences
persist even when males are given higher doses of AMPH to produce compa-
rable brain AMPH concentrations.42,62–66 One study reported gender differ-
ences in sensitization of AMPH-induced rotational behavior at a high dose of
AMPH, but not a low dose.42 This suggests gender differences in the dose-
effect curve for the induction and/or expression of sensitization, but very little
research has investigated or even characterized sex differences in
sensitization.
Most studies have reported that OVX in female rats does not affect the in-
duction or expression of sensitization to AMPH.42,62–64,66 However, estrogen
treatments in ovariectomized rats enhance sensitization of locomotor activity
induced by AMPH.66 Thus, variability in the behavior of intact female rats
across the estrous cycle may obscure the effects of ovarian hormones on the
induction and/or expression of sensitized psychomotor behaviors in experi-
ments in which intact and ovariectomized rats are compared.
Castration (CAST) of male rats has been reported to enhance sensitization
of AMPH-induced psychomotor behavior relative to intact males,42,62,63 but
not all investigators have found this result.66 If CAST enhances the induction
and/or expression of behavioral sensitization due to the removal of gonadal
steroid hormones, then testosterone treatment should reverse this effect. This
is not the case, however, as testosterone treatment does not suppress behav-
ioral sensitization in castrated male rats.66 (Our own unpublished data con-
firm this as well.) Thus, the role of testicular hormones in sensitization to
psychomotor stimulants remains an open question.
Research on gender differences in the sensitization of cocaine-induced be-
havioral activity is less problematic than is AMPH sensitization, as brain con-
centrations of cocaine afater peripheral metabolism are the same in males and
females67 and here again females exhibit greater behavioral sensitization.65
However, ovariectomized females have been reported not to show sensitiza-
tion of cocaine-induced locomotor activity when intact females or gonadal
hormone treated females do.55,65,68
In the Becker laboratory we have been investigating the role of gonadal ste-
roid hormones in behavioral sensitization and here describe the preliminary
results of two ongoing studies. The results of these studies illustrate two im-
portant points with regard to gender differences in behavioral sensitization to
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cocaine and the role of gonadal hormones in modulating sensitization. First,
we find gender differences in and hormonal influences on the specific behav-
iors that undergo behavioral sensitization. Second, estrogen enhances sensi-
tization of the female-specific behaviors in females rats, but not in males.
EXPERIMENT 1. GENDER DIFFERENCES IN SENSITIZATION
OF STEREOTYPED BEHAVIORS
In one study the influence of gonadal hormones on the development of sen-
sitization of stereotyped behaviors induced by cocaine was investigated in
adult male and female Sprague-Dawley rats. Four groups were compared:
ovariectomized (OVX; n = 10) females, ovariectomized females treated with
16 µg/kg estradiol benzoate (OVX + EB; n = 11), castrated (CAST; n = 11)
males, and SHAM castrated intact males (SHAM; n = 10). Surgery was per-
formed under pentobarbital anesthesia at least 2 weeks prior to the behavioral
tests. On test days, all animals received an injection of 0.1 ml peanut oil (s.c.)
30 minutes prior to cocaine, except for the OVX + EB group that received
16 µg/kg EB in 0.1 ml peanut oil (s.c.). Cocaine (15 mg/kg i.p.) was then ad-
ministered. Animals were videotaped for 30 minutes before and 30 minutes
after cocaine. Animals were tested for 4 consecutive days followed by 3 days
without treatment, for a period of 3 weeks (12 test days). Behaviors were
scored from videotape by an observer blind to the treatment group. The num-
bers of headbobs, forelimb movements, and midline crossings were counted
for 10 seconds every 5 minutes during the 30 minutes before injection and for
30 minutes after cocaine or saline injection. The totals for each type of move-
ment were used for analyses. The results of the first and last days of testing
are reported here.
As illustrated in FIGURE 1, the groups did not differ significantly on any of
the behaviors on day 1 (p >0.05), but exhibited different profiles of sensitiza-
tion for forelimb movements, midline crosses, and headbobs. For forelimb
FIGURE 1. Stereotyped behaviors induced by 15 mg/kg cocaine (i.p.) show dif-
ferent patterns of sensitization depending on the gender and gonadal hormone con-
dition of the rat. Forelimb movements (top panel): Female rats exhibit greater
sensitization than do male rats, and estrogen treatment further enhances sensitization
of ovariectomized females (*significantly greater than CAST and SHAM groups, p
<0.05); **significantly greater than all other groups, p <0.001). Midline Crosses
(middle panel): SHAM males did exhibit sensitization of midline crosses, while the
other groups did. (*behavior on day 12 significantly greater than that of the SHAM
male group, p <0.05). Headbobs (bottom panel): *SHAM and CAST males showed
an increase in headbobs with repeated exposure to cocaine (p <0.05); the other
groups did not.
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FIGURE 1. See previous page for legend.
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movements (top panel) there was a significant group effect on day 12 (F(3,38)
= 6.79; p <0.001), with the OVX + EB group exhibiting more forelimb move-
ments than did any other group (p <0.05). On paired t tests within each group,
only the OVX + EB and OVX groups exhibited an increase in forelimb move-
ments as a result of repeated cocaine treatment when day 1 and day 12 were
compared (p <0.005). In terms of the magnitude of the increase in forelimb
movements (day 12 minus day 1) there was a significant effect of group
(F(3,38) = 8.297, p <0.001), indicating group differences in sensitization. In
post-hoc tests, the OVX + EB group showed greater sensitization than did the
other three groups (p <0.001 vs CAST or SHAM males; p <0.05 vs OVX),
and the OVX group exhibited greater sensitization than did the CAST or
SHAM male groups (p <0.05).
For midline crosses (center panel) there was also a significant effect of
group on day 12 (F(3,38) = 3.37; p <0.03), with the OVX + EB group exhib-
iting more forelimb movements than did either of the male groups (p <0.05).
On paired t tests within each group (day 1 vs day 12), the OVX + EB, OVX,
and CAST groups exhibited an increase in midline crosses as a result of re-
peated cocaine treatment (p <0.01), whereas the SHAM males did not
(p = 0.117).
For headbobs (bottom panel) there was no effect of group on day 12
(F(3,38) = 0.394). On paired t tests within each group (day 1 vs day 12), only
the CAST and the SHAM male groups exhibited an increase in headbobs as
a result of repeated cocaine treatment (p <0.005). Repeated saline treatment
had no effect on any measure (data not shown).
Thus, estrogen treatment enhanced sensitization of forelimb movements,
but it did not affect locomotor behavior or headbobs. Furthermore, a sex dif-
ference was noted in the absence of gonadal hormones in sensitization of
forelimb movements. By contrast, when headbobs were examined, the male
groups exhibited sensitization, whereas the female groups did not. Finding
that there are gender differences in sensitization that are independent of go-
nadal hormones suggests that there may be organizational effects of gonadal
hormones on the neural systems mediating sensitization.
EXPERIMENT 2. GENDER DIFFERENCES IN SENSITIZATION
OF ROTATIONAL BEHAVIOR
In a second study, animals received unilateral 6-hydroxydopamine lesions
of the substantia nigra69 and 2 weeks later were ovariectomized or castrated
under pentobarbital anesthesia. Ovariectomized and castrated animals were
treated with 16 µg EB/kg or peanut oil as described above 30 minutes before












































FIGURE 2. Sensitization of rotational behavior in animals with unilateral dopamine depletion induced by 15 mg/kg cocaine in ovariecto-
mized (OVX) or CAST animals treated with either OIL or EB. All groups showed sensitization of this behavior, and two female groups exhibited
greater sensitization than did the two male groups. The OVX + EB group exhibited greater sensitization than did all other groups (p <0.05).
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+ EB, n = 11; CAST + OIL, n = 12). Rotational behavior was recorded for 1
hour after cocaine treatment in automated rotometers.70 Animals were tested
for 4 consecutive days followed by 3 days without treatment, for total of 12
cocaine treatments.
As illustrated in FIGURE 2, sensitization of rotational behavior also demon-
strates the sex differences in sensitization to 15 mg/kg. First, while there was
a tendency for the female groups to rotate more than male groups on day 1,
there was no significant effect of group (F(3,41) = 1.03, p = 0.388). We also
noted that all of the groups showed sensitization of rotational behavior, but
the two female groups exhibited greater sensitization than did the males.
(Group effect - F(3,41) = 7.033, p <0.001; Effect of Time - F(11, 41) =
25.638, <0.001; Group X Time interaction F(33,451) = 1.683, p <0.02). In
post-hoc comparisons, the OVX + EB group exhibited greater rotational be-
havior than did all other groups when the entire 12 days of behavior are com-
pared (p <0.05). The OVX group exhibited more rotational behavior than did
either of the male groups (p <0.05). EB treatment had no effect on rotational
behavior or sensitization in the CAST males. Thus, we again see gender dif-
ferences independent of gonadal hormones and an effect of EB to enhance
sensitization in female but not male rats.
CONCLUSIONS
The evidence reviewed indicates that estrogen has rapid, direct effects on
the striatum that act to enhance dopamine release and the behavioral response
to psychomotor stimulants in the female rat. Electrophysiological studies
suggest that this acute effect of estrogen is indirectly mediated by novel mem-
brane receptors for estradiol. The effect of estrogen on the striatum is sexual-
ly dimorphic, in that dopamine activity in the striatum of females is enhanced
by estrogen, but dopamine activity in the striatum of male rats is not affected
by estrogen.
There are also sexual dimorphisms in the neural systems mediating sensi-
tization to cocaine, in that female rats with or without ovarian hormones show
a more rapid rate of sensitization than do males if a particular behavior shows
sensitization in the female. However, it is not simply that females are more
responsive to the psychomotor stimulants or that they show greater sensitiza-
tion; there are also qualitative differences in the behaviors invoked by the ini-
tial response to these drugs as well as the way in which these behaviors
sensitize. Thus, there may be qualitative as well as quantitative sexual dimor-
phisms in the neural systems mediating the initial response to psychomotor
stimulants as well as the responses to repeated drug exposure.
183BECKER et al.: GENDER DIFFERENCES AND PSYCHOMOTOR STIMULANTS
ACKNOWLEDGMENTS
This work was supported by grants from the Horace H. Rackham Graduate
School and the National Science Foundation (BNS 9816673).
REFERENCES
1. WETHERINGTON, C.L. & A.R. ROMAN, Eds. 1995. Drug Addiction Research
and the Health of Women. U.S. Department of Health and Human Services.
Rockville, MD.
2. KANDEL, D.B., M.P.P. WARNER & R.C. KESSLER. 1995. The epidemiology of
substance abuse and dependence among women. In Drug Addiction Research
and the Health of Women. C.L. Wetherington & A.R. Roman, Eds: 105–130.
U.S. Department of Health and Human Services. Rockville, MD.
3. KOSTEN, T.R. et al. 1996. Gender differences in response to intranasal cocaine
administration to humans. Biol. Psychiatry 39: 147–148.
4. LUKAS, S.E. et al. 1996. Sex differences in plasma cocaine levels and subjec-
tive effects after acute cocaine administration in human volunteers. Psycho-
pharmacology 125: 346–354.
5. LYNCH, W. & M. CARROLL. 1999. Sex differences in the acquisition of intrave-
nously self-administered cocaine and heroin in rats. Psychopharmacology
144: 77–82.
6. LINDVALL, O. & A. BJORKLUND. 1974. The organization of the ascending cate-
cholamine neuron systems in the rat brain as revealed by the glyoxylic acid
fluorescence method. Acta Physiol. Scand. [Suppl] 412: 1–48.
7. UNGERSTEDT, U. 1971. Striatal dopamine release after amphetamine or nerve
degeneration revealed by rotational behavior. Acta Physiol. Scand. 82 (Suppl.
367): 49–68.
8. ARBUTHNOTT, G.W. & T.J. CROW, 1971. Relation of contraversive turning to
unilateral release of dopamine from the nigrostriatal pathway in rats. Exp.
Neurol. 30: 484–491.
9. COSTALL, B. & R.J. NAYLOR. 1977. Mesolimbic and extrapyramidal sites for
the mediation of stereotyped behavior patterns and hyperactivity by amphet-
amine and apomorphine in the rat. In Cocaine and Other Stimulants. E.H.
Ellinwood & M.M. Kilbey, Eds: 47–76. Plenum Press. New York. 
10. FINK, J.S. & G.P. SMITH, 1980. Relationships between selective denervation of
dopamine terminal fields in the naterior forebrain and behavioral responses to
amphetamine and apomorphine. Brain Res. 201: 107–127.
11. UNGERSTEDT, U. 1974. Functional dynamics of central monamine pathways. In
The Neurosciences: Third Study Program. F.O. Schmitt & F.G. Worden, Eds.:
979–988. MIT Press. Cambridge, MA. 
12. ROBINSON, T.E. & J.B. BECKER, 1983. The rotational behavior model: asym-
metry in the effects of unilateral 6–OHDA lesions of the substantia nigra in
rats. Brain Res. 264: 127–131.
184 ANNALS NEW YORK ACADEMY OF SCIENCES
13. BECKER, J.B., T.E. ROBINSON & K.A. LORENZ. 1982. Sex differences and
estrous cycle variations in amphetamine-elicited rotational behavior. Eur. J.
Pharmacol. 80: 65–72.
14. CAMP, D.M., J.B. BECKER & T.E. ROBINSON. 1986. Sex differences in the
effects of gonadectomy on amphetamine-induced rotational behavior in rats.
Behav. Neural. Biol. 46: 491–495.
15. ROBINSON, T.E., D.M. CAMP & J.B. BECKER. 1981. Gonadectomy attenuates
turning behavior produced by electrical stimulation of the nigrostriatal
dopamine system in female but not male rats. Neurosci. Lett. 23: 203–208.
16. BECKER, J.B. & M.E. BEER. 1986. The influence of estrogen on nigrostriatal
dopamine activity: behavioral and neurochemical evidence for both pre- and
postsynaptic components. Behav. Brain Res. 19: 27–33.
17. BECKER, J.B. 1990. Estrogen rapidly potentiates amphetamine-induced striatal
dopamine release and rotational behavior during microdialysis. Neurosci.
Lett. 118: 169–171.
18. BECKER, J.B. & C.N. RUDICK. 1999. Rapid effects of estrogen or progesterone on
the amphetamine-induced increase in striatal dopamine are enhanced by estro-
gen priming: a microdialysis study . Pharmacol. Biochem. Behav. 64: 53–57.
19. BECKER, J.B. & J. CHA. 1989. Estrous cycle-dependent variation in amphet-
amine-induced behaviors and striatal dopamine release assessed with
microdialysis. Behav. Brain Res. 35: 117–125.
20. CASTNER, S.A., L. XIAO & J.B. BECKER. 1993. Sex differences in striatal dopam-
ine: in vivo microdialysis and behavioral studies. Brain Res. 610: 127–134.
21. BECKER, J.B. 1990. Direct effect of 17β-estradiol on striatum: sex differences
in dopamine release. Synapse 5: 157–164.
22. BECKER, J.B. & V.D. RAMIREZ. 1981. Sex differences in the amphetamine
stimulated release of catecholamines from rat striatal tissue in vitro. Brain
Res. 204: 361–372.
23. XIAO, L. & J.B. BECKER. 1998. Effects of estrogen agonists on amphetamine-
stimulated striatal dopamine release. Synapse 29: 379–391.
24. MERMELSTEIN, P.G., J.B. BECKER & D.J. SURMEIER. 1996. Estradiol reduces
calcium currents in rat neostriatal neurons through a membrane receptor. J.
Neurosci. 16: 595–604.
25. KOOB, G.F. & F.E. BLOOM. 1988. Cellular and molecular mechanisms of drug
dependence. Science 242: 715–723.
26. STEWART, J. & A. BADIANI. 1993. Tolerance and sensitization to the behavioral
effects of drugs. Behav. Pharmacol. 4: 289–312.
27. JAFFE, J.H. 1990. Drug addiction and drug abuse. In The Pharmacological
Basis of Therapeutics. A.G. Gilman et al., Eds: 522–573. Pergamon Press.
New York. 
28. TIFFANY, S.T. 1990. A cognitive model of drug urges and drug-use behavior:
role of automatic and nonautomatic processes. Psychol. Rev. 97: 147–168.
29. WATSON, S.J. et al. 1989. Neuroanatomical and neurochemical substrates of
drug-seeking behavior: overview and future directions. In Molecular and Cel-
lular Aspects of the Drug Addictions. A. Goldstein, ed. :29–91. Springer-Ver-
lag. New York.
30. WISE, R.A. & M.A. BOZARTH. 1987. A psychomotor stimulant theory of addic-
tion. Psychol. Rev. 94: 469–492.
31. BERRIDGE, K.C. & T.E. ROBINSON. 1995. The mind of an addicted brain: neural
sensitization of wanting versus liking. Curr. Direct. Psychol. Sci. 4: 71–76.
185BECKER et al.: GENDER DIFFERENCES AND PSYCHOMOTOR STIMULANTS
32. DEMINIERE, J.M. et al. 1989. Experimental approach to individual vulnerability
to psychostimulant addiction. Neurosci. Biobehav. Rev. 13: 141–147.
33. HORGER, B.A., K. SHELTON & S. SCHENK. 1990. Preexposure sensitizes rats to
the rewarding effects of cocaine. Pharm. Biochem. Behav. 37: 707–711.
34. HORGER, B.A., M.K. GILES & S. SCHENK. 1992. Preexposure to amphetamine
and nicotine predisposes rats to self-administer a low dose of cocaine. Psy-
chopharmacology 107: 271–276.
35. LETT, B.T. 1989. Repeated exposures intensify rather than diminish the reward-
ing effects of amphetamine, morphine, and cocaine. Psychopharmacology
(Berl.) 98: 357–362.
36. PIAZZA, P.V. et al. 1991. Individual vulnerability to drug self-administration:
action of corticosterone on dopaminergic systems as a possible pathophysio-
logical mechanism. In The Mesolimbic Dopamine System: From Motivation
to Action. P. Willner & J. Scheel-Krüger, Eds..: 473–495. John Wiley & Sons
Ltd. New York.
37. ROBINSON, T.E. 1993. Persistent sensitizing effects of drugs on brain dopamine
systems and behavior: implications for addiction and relapse. In Biological
Basis of Substance Abuse. S.G. Korenman & J.D. Barchas, Eds.: 373–402.
Oxford University Press. New York. 
38. ROBINSON, T.E. & K.C. BERRIDGE. 1993. The neural basis of drug craving: an
incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247–291.
39. SCHENK, S. et al. 1992. Blockade of sensitizing effects of amphetamine preex-
posure on cocaine self-administration by the NMDA antagonist MK-801.
Soc. Neurosci. Abstr. 18: 1237.
40. KALIVAS, P.W. & J. STEWART. 1991. Dopamine transmission in the initiation
and expression of drug- and stress-induced sensitization of motor activity.
Brain Res. Rev. 16: 223–244.
41. ROBINSON, T.E. et al. 1985. Enduring enhancement in frontal cortex dopamine
utilization in an animal model of amphetamine psychosis. Brain Res. 343:
374–347.
42. ROBINSON, T.E. 1984. Behavioral sensitization: characterization of enduring
changes in rotational behavior produced by intermittent injections of amphet-
amine in male and female rats. Psychopharmacology (Berl.) 84: 466–475.
43. SHIPPENBERG, T.S. & C. HEIDBREDER. 1995. Sensitization to the conditioned
rewarding effects of cocaine: pharmacological and temporal characteristics. J.
Pharmacol. Exp. 273: 808–815.
44. SHIPPENBERG, T.S., C. HEIDBREDER & A. LEFEVOUR. 1996. Sensitization to the
conditioned rewarding effects of morphine: pharmacology and temporal char-
acteristics. Eur. J. Pharmacol. 299: 33–39.
45. SHIPPENBERG, T.S., A. LEFEVOUR & C. HEIDBREDER. 1996. k-opioid receptor
agonists prevent sensitization to the conditioned rewarding effects of cocaine.
J. Pharmacol. Exp. Ther. 276: 545–554.
46. PIAZZA, P.V. et al. 1989. Factors that predict individual vulnerability to amphet-
amine self-administration. Science 245: 1511–1513.
47. PIAZZA, P.V. et al. 1990. Stress- and pharmacologically-induced behavioral
sensitization increases vulnerability to acquisition of amphetamine self-
administration. Brain Res. 514: 22–26.
48. WOOLVERTON, W.L., L.I. GOLDBERG & J.Z. GINOS. 1984. Intravenous self-
administration of dopamine receptor agonists by rhesus monkeys. J. Pharma-
col. Exp. Ther. 230: 678–683.
186 ANNALS NEW YORK ACADEMY OF SCIENCES
49. PIERRE, P. & P. VEVINA. 1997. Predisposition to self-administer amphetamine:
the contribution of response to novelty and prior exposure to the drug. Psy-
chopharmacology 129: 277–284.
50. VALADEZ, A. & S. SCHENK. 1994. Persistence of the ability of amphetamine
preexposure to facilitate acquisition of cocaine self-administration. Pharma-
col. Biochem. Behav. 47: 203–205.
51. ROBINSON, T.E. & J.B. BECKER. 1986. Enduring changes in brain and behavior
produced by chronic amphetamine administration: a review and evaluation of
animal models of amphetamine psychosis. Brain Res. 396: 157–198.
52. PAULSON, P.E., D.M. CAMP & T.E. ROBINSON. 1991. Time course of transient
behavioral depression and persistent behavioral sensitization in relation to
regional brain monoamine concentrations during amphetamine withdrawal in
rats. Psychopharmacology (Berl.) 103: 480–492.
53. HENRY, D.J. & F.J. WHITE. 1995. The persistence of behavioral sensitization to
cocaine parallels enhanced inhibition of nucleus accumbens neurons. J. Neu-
rosci. 15: 6287–6299. 
54. JANAK, P.A. et al. 1997. Rapid decay of cocaine-induced behavioral sensitiza-
tion of locomotor behavior. Behav. Brain Res. 88: 195–199.
55. SIRCAR, R. & D. KIM. 1999. Female gonadal hormones differentially modulate
cocaine-induced behavioral sensitization in Fischer, Lewis and Sprague-Daw-
ley rats. J. Pharmacol. Exp. Ther. 289: 54–65.
56. POST, R.M., S.R. WEISS & A. PERT. 1987. The role of context and conditioning
in behavioral sensitization to cocaine. Psychopharmacol. Bull. 23: 425–429.
57. SEGAL, D.S. & M.A. SCHUCKIT. 1983. Animal models of stimulant-induced
psychosis. In Stimulants: Neurochemical, Behavioral and Clinical Perspec-
tives. I. Creese, ed. :131–167. Raven Press. New York. 
58. SEGAL, D.S. & R. KUCZENSKI. 1994. Behavioral pharmacology of amphet-
amine. In Amphetamine and Its Analogs: Psychopharmacology, Toxicology
and Abuse. A.K. Cho & D.S. Segal, Eds.: 115–150. Academic Press, Inc. San
Diego.
59. WHITE, F.J. & M.E. WOLF. 1991. Psychomotor stimulants. In The Biological
Bases of Drug Tolerance and Dependence. J. Pratt, ed. :153–197. Academic
Press. New York.
60. ROBINSON, T.E. 1988. Stimulant drugs and stress: factors influencing individ-
ual differences in the susceptibility to sensitization. In Sensitization of the
Nervous System. P.W. Kalivas & C. Barnes, Eds.: 145–173. Telford Press.
Caldwell, NJ. 
61. ROBINSON, T.E. 1991. The neurobiology of amphetamine psychosis: evidence
from studies with an animal model. In Taniguchi Symposia on Brain Sci-
ences, Vol. 14. Biological Basis of Schizophrenia. T. Nakazawa, ed. :185–
201. Japan Scientific Societies Press. Tokyo. 
62. CAMP, D.M. & T.E. ROBINSON. 1988. Susceptibility to sensitization. II. The
influence of gonadal hormones on enduring changes in brain monoamines
and behavior produced by the repeated administration of D-amphetamine or
restraint stress. Behav. Brain Res. 30: 69–88.
63. CAMP, D.M. & T.E. ROBINSON. 1988. Susceptibility to sensitization. I. Sex dif-
ferences in the enduring effects of chronic D-amphetamine treatment on loco-
motion, stereotyped behavior and brain monoamines. Behav. Brain Res. 30:
55–68.
187BECKER et al.: GENDER DIFFERENCES AND PSYCHOMOTOR STIMULANTS
64. ROBINSON, T.E., J.B. BECKER & S.K. PRESTY. 1982. Long-term facilitation of
amphetamine-induced rotational behavior and striatal dopamine release pro-
duced by a single exposure to amphetamine: sex differences. Brain Res. 253:
231–241.
65. VAN HAAREN, F. & M. MEYER. 1991. Sex differences in the locomotor activity
after acute and chronic cocaine administration. Pharmacol. Biochem. Behav.
39: 923–927.
66. FORGIE, M.L. & J. STEWART. 1994. Sex difference in amphetamine-induced
locomotor activity in adult rats: role of testosterone exposure in the neonatal
period. Pharmacol. Biochem. Behav. 46: 637–645.
67. BOWMAN, B.P. et al. 1999. Effects of sex and gonadectomy on cocaine metabo-
lism in the rat. J. Pharm. Exp. Ther. 290: 1316–1323.
68. PERIS, J. et al. 1991. Estradiol enhances behavioral sensitization to cocaine and
amphetamine-stimulated [3H]dopamine release. Brain Res. 566: 255–264.
69. CURRAN, E.J., R.L. ALBIN & J.B. BECKER. 1993. Adrenal medulla grafts in the
hemiparkinsonian rat: profile of behavioral recovery predicts restoration of
the symmetry between the two striata in measures of pre- and postsynaptic
dopamine function. J. Neurosci. 13: 3864–3877.
70. MCFARLANE, D.K., B.J. MARTONYI & T.E. ROBINSON. 1992. An inexpensive
automated system for the measurement of rotational behavior in small ani-
mals. Behav. Res. Meth. Inst. & Computers 24: 414–419.
